Damaris (XPAR:MLDAM) Research & Development: €0.00 Mil (TTM As of Dec. 2025)


XPAR:MLDAM Damaris SA XPAR:MLDAM
29 GF Score
Price €6.75
! 2 Warning Signs
View Full Analysis

What is Damaris Research & Development?

Damaris XPAR:MLDAM 29 Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus rates XPAR:MLDAM with a GF Score™ of 29/100. The stock has 2 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Damaris's Research & Development for the six months ended in Dec. 2025 was €0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

Damaris  (XPAR:MLDAM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Damaris Research & Development Related Terms

Damaris Research & Development Historical Data

* Premium members only.

The historical data trend for Damaris's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Damaris Research & Development Chart

Damaris Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Research & Development
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Damaris Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Dec22 Dec23 Dec24 Dec25
Research & Development Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00
XPAR:MLDAM
29GF Score
Damaris SA XPAR:MLDAM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Damaris Research & Development Calculation

This is the expense the company spent on research and development.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of €0.00 Mil mean?
Damaris (XPAR:MLDAM) has a Research & Development of €0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Damaris and its competitors.
Is Damaris' Research & Development too high?
Damaris' current Research & Development is €0.00 Mil. Overall, Damaris has a GF Score™ of 29/100, reflecting its overall financial health beyond just this single metric.
How does Damaris' Research & Development compare to CRM and SHOP?
Damaris' Research & Development of €0.00 Mil can be compared against companies in the Software industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Software company?
A good Research & Development depends on the Software industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Damaris and its competitors. Damaris's current Research & Development is €0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Damaris stock overvalued right now?
Damaris (XPAR:MLDAM) has a current Research & Development of €0.00 Mil. The current Research & Development is €0.00 Mil. Damaris' overall GF Score™ is 29/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Damaris (XPAR:MLDAM), the current Research & Development is €0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Damaris Business Description

Address 9 chemin du Jublin, Dardilly, FRA, 69570
Damaris SA specializes in the design and publishing of software packages for secured document sharing and storage. The company deals in license sales for physical storage and accounting document management and sales of special peripherals.
29GF Score

Get the complete analysis for XPAR:MLDAM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€6.75
Price